Published in Mol Pathol on December 01, 1998
Increased proliferation and apoptosis of colonic epithelial cells in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci (2002) 1.28
Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J Gastroenterol (2011) 1.23
miR-143 and miR-145 are downregulated in ulcerative colitis: putative regulators of inflammation and protooncogenes. Inflamm Bowel Dis (2011) 1.20
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol (2014) 0.86
Reduced hTERT protein levels are associated with DNA aneuploidy in the colonic mucosa of patients suffering from longstanding ulcerative colitis. Int J Mol Med (2014) 0.84
Endoscopic and pathological aspects of colitis-associated dysplasia. Nat Rev Gastroenterol Hepatol (2009) 0.83
Microscopic features of colorectal neoplasia in inflammatory bowel diseases. World J Gastroenterol (2014) 0.81
The measurement of observer agreement for categorical data. Biometrics (1977) 216.56
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol (1984) 17.76
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Rectal biopsy as an aid to cancer control in ulcerative colitis. Gut (1967) 7.39
Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol (1992) 6.13
Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol (1991) 3.82
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Cancer in colitis: assessment of the individual risk by clinical and histological criteria. Gastroenterology (1977) 2.61
Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology (1993) 2.52
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Phase 1 and phase 2 proliferative lesions of colonic epithelial cells in diseases leading to colonic cancer. Cancer (1974) 1.95
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology (1990) 1.59
Cell cycle dependent expression and stability of the nuclear protein detected by Ki-67 antibody in HL-60 cells. Cell Prolif (1992) 1.58
The pattern of cell proliferation in neoplastic and nonneoplastic lesions of ulcerative colitis. Cancer (1996) 1.57
Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology (1994) 1.41
Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations. J Pathol (1988) 1.36
Correlations between rectal mucosa cell proliferation and the clinical and pathological features of nonfamilial neoplasia of the large intestine. Cancer Res (1991) 1.25
Fluorescence staining of gastric mucosa. A study with special reference to parietal cells. Scand J Gastroenterol (1977) 1.18
Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut (1991) 1.15
Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen? Cancer Epidemiol Biomarkers Prev (1997) 1.10
Early proliferative changes in gastrointestinal neoplasia. Am J Gastroenterol (1982) 1.08
Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res (1992) 1.07
Ki-67-determined growth fraction versus standard staging and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer (1992) 1.07
Rectal cell proliferation and colon cancer risk in ulcerative colitis. Cancer Res (1990) 1.02
Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa. Hum Pathol (1989) 0.92
Ki-67 antibody labeling index in colorectal carcinoma. J Clin Gastroenterol (1992) 0.86
Control of thymidine incorporation in mucosal explants from patients with chronic ulcerative colitis. Gastroenterology (1980) 0.85
Proliferative defects in ulcerative colitis patients. Cancer Invest (1983) 0.83
Validation of a simple technique for the detection of abnormal mucosal cell replication in humans. Eur J Cancer Prev (1994) 0.80
Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer. Am J Gastroenterol (1994) 0.77
Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease. Eur J Gastroenterol Hepatol (1996) 0.77
Immunohistochemical detection of proliferating cells in colorectal carcinomas and adenomas with the monoclonal antibody Ki-67. Preliminary data. Virchows Arch A Pathol Anat Histopathol (1989) 0.76
Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer (2001) 5.36
Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 4.93
Is the use of dummy or carry-cot of importance for sudden infant death? Eur J Pediatr (1997) 3.06
Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology (1989) 2.98
Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg (2003) 2.54
Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology (1987) 1.76
Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi. J Nucl Med (1997) 1.69
Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology (1997) 1.62
Lymphoepithelial interactions in the mucosal immune system. Gut (1988) 1.58
Germline and somatic mutations in exon 15 of the APC gene and K-ras mutations in duodenal adenomas in patients with familial adenomatous polyposis. Scand J Gastroenterol (1999) 1.58
Different genetic pathways to proximal and distal colorectal cancer influenced by sex-related factors. Int J Cancer (1997) 1.57
Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet (1995) 1.57
WNT1 inducible signaling pathway protein 3, WISP-3, a novel target gene in colorectal carcinomas with microsatellite instability. Gastroenterology (2001) 1.56
Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med (1998) 1.55
Objective measurements of nicotine exposure in victims of sudden infant death syndrome and in other unexpected child deaths. J Pediatr (1998) 1.46
Assessment of mucosal inflammation and blood flow in response to four weeks' intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA). Scand J Gastroenterol (2004) 1.44
The human gastrointestinal secretory immune system in health and disease. Scand J Gastroenterol Suppl (1985) 1.44
Comparative epidemiology of sudden infant death syndrome and sudden intrauterine unexplained death. Arch Dis Child Fetal Neonatal Ed (2002) 1.43
Deletion of 1p loci and microsatellite instability in colorectal polyps. Genes Chromosomes Cancer (1995) 1.43
[Sudden infant death and sleeping position]. Tidsskr Nor Laegeforen (1992) 1.38
Evaluation of tissue preparation methods and paired immunofluorescence staining for immunocytochemistry of lymphomas. Histochem J (1983) 1.34
K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer (1994) 1.31
Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer (1999) 1.28
Safety and efficacy of dynamic graciloplasty for fecal incontinence: report of a prospective, multicenter trial. Dynamic Graciloplasty Therapy Study Group. Dis Colon Rectum (2000) 1.24
Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas? Br J Cancer (1983) 1.20
Intradermal ras peptide vaccination with granulocyte-macrophage colony-stimulating factor as adjuvant: Clinical and immunological responses in patients with pancreatic adenocarcinoma. Int J Cancer (2001) 1.18
Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD). Clin Exp Immunol (1997) 1.18
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation. Lancet (1995) 1.17
Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis. Br J Cancer (1991) 1.12
Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut (1995) 1.11
Changes in the epidemiological pattern of sudden infant death syndrome in southeast Norway, 1984-1998: implications for future prevention and research. Arch Dis Child (2001) 1.09
Molecular genetic analysis of long QT syndrome in Norway indicating a high prevalence of heterozygous mutation carriers. Scand J Clin Lab Invest (2008) 1.09
Distribution of mucosal IgA and IgG subclass-producing immunocytes and alterations in various disorders. Monogr Allergy (1986) 1.08
Ontogeny of the mucosal immune system and IgA deficiency. Gastroenterol Clin North Am (1991) 1.07
Large-bowel carcinomas with different ploidy, related to secretory component, IgA, and CEA in epithelium and plasma. Br J Cancer (1982) 1.06
SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis. Oncogene (2011) 1.06
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut (2002) 1.05
Increased number of substitutions in the D-loop of mitochondrial DNA in the sudden infant death syndrome. Acta Paediatr (1998) 1.05
Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am J Physiol Heart Circ Physiol (2000) 1.05
The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer (1999) 1.05
Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. J Clin Pathol (2005) 1.02
Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. Carcinogenesis (1991) 1.01
Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer (2002) 1.00
Resistance against cis-dichlorodiammineplatinum in cultured cells with a high content of metallothionein. Toxicol Appl Pharmacol (1981) 0.99
TP53 and long-term prognosis in colorectal cancer: mutations in the L3 zinc-binding domain predict poor survival. Clin Cancer Res (1998) 0.98
Regulation of survival of rat pachytene spermatocytes by lactate supply from Sertoli cells. J Reprod Fertil (1982) 0.98
Immunohistochemical evaluation of carcinoembryonic antigen, secretory component, and epithelial IgA in ulcerative colitis with dysplasia. Gut (1982) 0.98
Increased immune response in upper respiratory and digestive tracts in SIDS. Lancet (1990) 0.97
Sudden infant death syndrome victims show local immunoglobulin M response in tracheal wall and immunoglobulin A response in duodenal mucosa. Pediatr Res (1992) 0.96
Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype. Mol Pathol (1998) 0.96
P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo. Br J Cancer (1995) 0.95
APC and CTNNB1 mutations in a large series of sporadic colorectal carcinomas stratified by the microsatellite instability status. Scand J Gastroenterol (2002) 0.95
Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br J Cancer (1993) 0.95
Production and secretion of immunoglobulins in the gastrointestinal tract. Ann Allergy (1987) 0.95
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study. Int J Cancer (1996) 0.95
K-ras mutations and HLA-DR expression in large bowel adenomas. Br J Cancer (1996) 0.94
Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity. Cancer (1997) 0.94
Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery (1992) 0.93
Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol (1999) 0.93
K-ras mutations and prognosis in large-bowel carcinomas. Scand J Gastroenterol (1997) 0.93
Radioresistance in cells with high content of metallothionein. Experientia (1982) 0.93
Cellular localization of the Mn2+-dependent adenylyl cyclase (AC) in rat testis. Int J Androl (1981) 0.92
Biliary dysplasia as a marker of cholangiocarcinoma in primary sclerosing cholangitis. J Hepatol (2001) 0.92
Increased resistance to chlorambucil in cultured cells with a high concentration of cytoplasmic metallothionein. Cancer Res (1983) 0.92
Immunoglobulin-producing cells in the "transitional" mucosa adjacent to adenocarcinomas of the human large bowel. Int J Cancer (1979) 0.91
Metabolism of zinc and copper in the neonate: accumulation and function of (Zn, Cu)-metallothionein in the liver of the newborn rat. Br J Nutr (1981) 0.91
Distribution of immunoglobulin producing cells is different in normal human appendix and colon mucosa. Gut (1986) 0.91
Expression of Bcl-2 family proteins and spontaneous apoptosis in normal human testis. Mol Hum Reprod (2001) 0.90
Some effects of bleomycin on the proliferation, maturation time and protein synthesis of hairless mouse epidermis. Cell Tissue Kinet (1976) 0.90
Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis (2001) 0.90
Mitochondrial DNA point mutations detected in four cases of sudden infant death syndrome. Acta Paediatr (1999) 0.89
Outcome of four weeks' intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand J Gastroenterol (2005) 0.89
Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development. J Hepatol (2000) 0.89
Immunohistochemistry of epithelial cell markers in normal and pathological colon mucosa. Comparison of results based on routine formalin- and cold ethanol-fixation methods. Histochemistry (1980) 0.89
Age-related changes of human serum antibodies to dietary and colonic bacterial antigens measured by an enzyme-linked immunosorbent assay. Acta Pathol Microbiol Immunol Scand C (1985) 0.89
Secular trends of sudden infant death syndrome in Norway 1967-1988: application of a method of case identification to Norwegian registry data. Paediatr Perinat Epidemiol (1994) 0.89
SIDS cases have increased levels of interleukin-6 in cerebrospinal fluid. Acta Paediatr (1995) 0.89
Altered hormonal response to short-term bicycle exercise in young men after prolonged physical strain, caloric deficit, and sleep deprivation. Eur J Appl Physiol Occup Physiol (1980) 0.88
Characterization of a human epithelial cell line with special reference to its ultrastructure. Acta Pathol Microbiol Scand A (1981) 0.88
Elevated levels of secretory immunoglobulins A and M in serum of patients with large bowel carcinoma indicate liver metastasis. Cancer (1987) 0.88
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation? Int J Cancer (1994) 0.87
Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology (1997) 0.87
Evaluation of nine different fixatives. 1. Preservation of immunoglobulin isotypes, J chain, and secretory component in human tissues. Pathol Res Pract (1984) 0.87
Cellular localization of the Mn2+-dependent adenylyl cyclase in the human testis. Arch Androl (1982) 0.87
Assessment of mucosal inflammation and circulation in response to probiotics in patients operated with ileal pouch anal anastomosis for ulcerative colitis. Scand J Gastroenterol (2003) 0.86
Preservation of cytometric DNA distribution and epithelial marker expression after tumor progression of human large bowel carcinomas. Cancer (1985) 0.86
Performance testing of antigen-coated polystyrene microplates for ELISA measurements of serum antibodies to bacterial and dietary antigens. Acta Pathol Microbiol Immunol Scand C (1985) 0.86
p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head. Int J Oncol (2000) 0.86
Presence of isolated tumour cells in mesenteric lymph nodes predicts poor prognosis in patients with stage II colon cancer. Eur J Surg Oncol (2003) 0.86
Inflammatory responses in sudden infant death syndrome -- past and present views. FEMS Immunol Med Microbiol (1999) 0.85
Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study? Cancer (1991) 0.85
The TP53 tumour suppressor gene in colorectal carcinomas. I. Genetic alterations on chromosome 17. Br J Cancer (1993) 0.85
The pathological approach to sudden infant death--consensus or confusion? Recommendations from the Second SIDS Global Strategy Meeting, Stavangar, Norway, August 1994, and the Third Australasian SIDS Global Strategy Meeting, Gold Coast, Australia, May 1995. Am J Forensic Med Pathol (1996) 0.85
CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer. Genes Immun (2011) 0.85
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines. Br J Cancer (1996) 0.85